Multivirus-specific cytotoxic T lymphocytes (Children's Research Institute)

多病毒特异性细胞毒性T淋巴细胞

Report date: 2026/03/13 20:02:36

Base Information

Drug NameMultivirus-specific cytotoxic T lymphocytes (Children's Research Institute)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy
Mechanisms of ActionUpdating
TargetsNot applicable
Therapy Area/IndicationsEpstein-Barr Virus InfectionsCytomegalovirus InfectionsAdenoviridae Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesCatherine Bollard Children'S Research Institute
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesChildren'S National Research InstituteCatherine Bollard Children'S Research Institute
Active IndicationsN/A
Inactive IndicationsEpstein-Barr Virus InfectionsCytomegalovirus InfectionsAdenoviridae Infections

Other Information

ATC CodeN/A
Related LinksN/A